Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sepracor-Looks very promising -- Ignore unavailable to you. Want to Upgrade?

To: quidditch who wrote (2452)	4/19/1999 5:36:00 PM
From: BMcV	Read Replies (1) \| Respond to of 10280

Nothing really, just a lil' running food fight some on this board have with the Bear Stearns analyst David Maris. He served as the main source for a very bearish WSJ article on Sepracor, that coincided with both a low (and turnaround) in the stock and his first SEPR downgrade on value concerns. He hadn't covered the stock long and seemed not to fully understand what they do. Looking back, I think his analysis was off-the-cuff more than anything else ("stock's up to 60 from where I recommended it at 45, no earnings, no revenues, think we should unload it and go with a more established company"), but it did push down further the stock that was already quite weak. His pick going forward was Alza, which hasn't done much since. Good times or bad, it's always fun to remind folks of this.